Mar 2026 CRCC.CN Copland Road (CNQ) C$0.13 on volume spike: liquidity test

A sharp intraday volume spike pushed Copland Road Capital Corporation (CRCC.CN) on the CNQ to C$0.13 during market hours on Mar 2026. The stock traded between C$0.125 and C$0.13 with 16,000 shares changing hands versus an average volume of 407.00, giving a relative volume of 39.31. This sudden activity makes the CRCC.CN stock a short-term liquidity play for traders watching order flow and bid-ask spreads.

CRCC.CN stock: Volume spike and trading activity

The volume spike for CRCC.CN occurred while the Canadian market was open, highlighting an unusually large intraday trade count. Price held at C$0.13 with a day low of C$0.125 and a day high of C$0.13. The market cap is C$1,438,905.00 and shares outstanding are 11,068,500.00. Traders should note the average volume is 407.00, so today’s 16,000 volume represents a liquidity surge that may not persist into the next session.

Fundamentals and valuation for CRCC.CN stock

Copland Road Capital is listed on CNQ in Canada and operates in the Healthcare sector, focused on cannabis investments. Trailing metrics are weak: EPS -0.05, PE -2.60, and Price/Book 2.51. The company shows large cash ratios with current ratio 15.37 and cash per share C$0.03, but negative returns: ROE -0.93 and ROA -1.05. These figures underline a small-cap investment with limited earnings and material downside risks.

Technicals and trend signals for CRCC.CN stock

Price sits just under the 50-day average of C$0.14 and below the 200-day average of C$0.17, suggesting short-term weakness inside a longer-term lower trend. ADX reads 100.00 indicating a strong short-term trend during the spike. Year range is C$0.125 to C$0.195, so immediate technical targets are the day support near C$0.125 and resistance at the year high C$0.195.

Meyka AI grade and forecast for CRCC.CN stock

Meyka AI rates CRCC.CN with a score out of 100: 63.39 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12‑month price of C$0.16849, implying an upside of 29.61% from the current C$0.13. Forecasts are model-based projections and not guarantees, and should be used alongside fundamental review.

Risks, sector context, and catalysts for CRCC.CN stock

CRCC.CN sits in Healthcare and the Drug Manufacturers – Specialty & Generic industry but operates as an investment firm focused on U.S. cannabis deals. Key risks include thin liquidity, negative earnings, potential equity dilution, and limited analyst coverage. Sector averages show much higher PE and ROE, so Copland Road’s profile is atypical for healthcare peers. Recent market mention in a competitor comparison is available via Investing.com comparison.

Trading strategy: Volume-spike playbook for CRCC.CN stock

For volume-spike traders, watch whether volume stays above 1,000.00 shares and whether price closes above the 50-day average C$0.14 on follow-through. A conservative short-term price target is C$0.20, with a nearer-term resistance target at C$0.195. Set tight risk controls given low liquidity and consider exits near the year low C$0.125 if volume fades. See the Meyka internal profile for live metrics: Meyka stock page.

Final Thoughts

The CRCC.CN stock moved to C$0.13 on a clear volume spike during market hours in Mar 2026. The trade shows a temporary liquidity window: 16,000 shares traded versus an average of 407.00, so short-term traders can exploit tighter spreads and momentum. Fundamentals remain weak with EPS -0.05 and PE -2.60, and the company trades below its 200-day average C$0.17. Meyka AI’s forecast model projects C$0.16849 over the next 12 months, implying a 29.61% upside from C$0.13, though that forecast is model-based and not guaranteed. Given the Meyka AI grade of 63.39 (B, HOLD) and the sector context, CRCC.CN is best approached as a speculative volume‑driven trade where strict entry and exit rules matter. Use position sizing to limit capital at risk and confirm follow-through volume before adding exposure.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.